Skip to main content

Table 2 Ivermectin MDA coverage and mosquito population changes in the intervention communities

From: Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria

  

Kugba-Ajagbe

Amini

p-value

No of eligible persons surveyed

 Female

 

32

23

 

 Male

 

29

18

 

 Total

 

61

41

 

No. of persons treated (%)

 Female

 

17 (68.0)

14 (51.9)

 

 Male

 

8 (32.0)

13 (48.1)

 

 Total coverage

 

25 (41.0)

27 (65.9)

0.024*

Anopheles sp.

 Indoor density

14–13 days before MDA

1.97

0.90

 

2–3 days post-MDA

1.70 (p = 0.446)

0.33 (p = 0.005)

 

13–14 days post-MDA

1.93 (p = 0.926)

0.97 (p = 0.789)

 

 Outdoor density

14–13 days before MDA

1.00

0.17

 

2–3 days post-MDA

0.83 (p = 0.763)

1.00 (0.068)

 

13–14 days post-MDA

0.33 (p = 0.157)

0.00

 

 Indoor parity rate

14–13 days before MDA

96.61

92.59

 

2–3 days post-MDA

45.10 (p < 0.001)

40.00 (p = 0.002)

 

13–14 days post-MDA

67.24 (p < 0.001)

93.10 (p = 0.667)

 

 Outdoor parity rate

14–13 days before MDA

83.33

100.00

 

2–3 days post-MDA

80.00 (p = 0.727)

50.00 (p = 0.600)

 

13–14 days post-MDA

0.00 (p = 0.107)

 

Culex sp.

 Indoor density

14–13 days before MDA

0.13

0.00

 

2–3 days post-MDA

0.07 (p = 0.414)

0.13

 

13–14 days post-MDA

0.23 (p = 0.366)

0.27

 

 Outdoor density

14–13 days before MDA

1.50

4.17

 

2–3 days post-MDA

5.33 (p < 0.001)

1.75 (p = 0.036)

 

13–14 days post-MDA

1.50 (p = 1.000)

0.50 (p = 0.001)

 

 Indoor parity rate

14–13 days before MDA

100.00

 

2–3 days post-MDA

100.00

100.00

 

13–14 days post-MDA

100.00

87.50

 

 Outdoor parity rate

14–13 days before MDA

88.89

64.00

 

2–3 days post-MDA

96.88 (p = 0.395)

100.00 (p = 0.073)

 

13–14 days post-MDA

88.89 (p = 0.765)

100.00 (p = 0.436)

 
  1. *Difference between total MDA coverage is statistically significant
  2. Density or parity rate is statistically significantly higher or lower than before MDA